A mapping for managers: open innovation for R&D intensive SMEs in the life sciences sector

被引:9
|
作者
Marangos, Stefanos [1 ]
Warren, Lorraine [2 ]
机构
[1] Bournemouth Univ, Dept Leadership Strategy & Org, Sch Business, Bournemouth, Dorset, England
[2] Massey Univ, Sch Management, Innovat & Entrepreneurship, Palmerston North, New Zealand
关键词
SME; CEOs; Strategies; Open innovation; Life sciences; R&D intensive; BIO-PHARMACEUTICAL INDUSTRY; INBOUND OPEN INNOVATION; HIGH-TECH SMES; ABSORPTIVE-CAPACITY; DRUG DISCOVERY; SMALL FIRMS; TECHNOLOGY; KNOWLEDGE; NETWORKS; PERFORMANCE;
D O I
10.1108/EJIM-12-2015-0133
中图分类号
F [经济];
学科分类号
02 ;
摘要
Purpose - The purpose of this paper is to examine what strategies the CEOs of research and development (R&D) intensive small/medium enterprises (SMEs) in the life sciences sector carry out in regard to open innovation (OI), as R&D costs continue to rise, placing pressure on innovation managers. Design/methodology/approach - A qualitative study was carried out, consisting of 30 semi-structured interviews with CEOs of small R&D intensive SMEs in the life sciences sector. The authors analysed the key factors identified by the CEOs in relation to their OI strategies. Findings - SMEs adopt a range of OI strategies and collaborations, subject to certain conditions. A multilevel mapping developed from the analysis connects actors to the wider domain, setting the outcomes of the research in context. Research limitations/implications - This qualitative study provides detailed understandings that could provide the basis for a wider quantitative study that would provide greater coverage of the sector, thus reinforcing the outcomes. Practical implications - The study will be relevant to practising CEOs who are considering the range of options offered by OI. Originality/value - While large firms are adopting OI strategies, less is known about the OI strategies developed in SMEs. The study addresses that gap. The life sciences context is also novel.
引用
收藏
页码:210 / 229
页数:20
相关论文
共 50 条
  • [1] Driving efficiency and innovation in life sciences R&D
    Donahue, Joseph
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [2] Open Innovation, R&D Collaboration and Global Strategy in Hightech SMEs: Focused on R&D Collaboration Mode
    Jeon, Rara
    Dagravel, Daniel
    [J]. PROCEEDINGS OF THE 5TH INTERNATIONAL CONFERENCE ON INNOVATION AND ENTREPRENEURSHIP (ICIE 2017), 2017, : 52 - 60
  • [3] Effects of SME collaboration on R&D in the service sector in open innovation
    Suh, Yongyoon
    Kim, Moon-Soo
    [J]. INNOVATION-ORGANIZATION & MANAGEMENT, 2012, 14 (03): : 349 - 362
  • [4] R&D MATTERS IN SMEs R&D AS A STRATEGIC ELEMENT FOR INNOVATION AND MARKET SUCCESS
    Spielkamp, Alfred
    Rammer, Christian
    [J]. BUSINESS EXCELLENCE, 2006, : 445 - 454
  • [5] R&D Information Sources and Innovation Behavior of SMEs
    Chi Renyong
    Shou Xiuhua
    [J]. PROCEEDINGS OF THE TWELFTH WEST LAKE INTERNATIONAL CONFERENCE ON SMALL & MEDIUM BUSINESS (WLICSMB 2010), 2011, : 193 - 199
  • [6] R&D in Indian life sciences sector gets incentives from UK
    Ashwini, S. K.
    [J]. CURRENT SCIENCE, 2013, 105 (05): : 572 - 572
  • [7] Open R&D and open innovation: exploring the phenomenon
    Enkel, Ellen
    Gassmann, Oliver
    Chesbrough, Henry
    [J]. R & D MANAGEMENT, 2009, 39 (04) : 311 - 316
  • [8] Reinventing R&D in an Open Innovation Ecosystem
    Traitler, Helmut
    Watzke, Heribert J.
    Saguy, I. Sam
    [J]. JOURNAL OF FOOD SCIENCE, 2011, 76 (02) : R62 - R68
  • [9] Open innovation and patterns of R&D competition
    Lim, Kwanghui
    Chesbrough, Henry
    Ruan, Yi
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY MANAGEMENT, 2010, 52 (3-4) : 295 - 321
  • [10] BAYER TOUTS LIFE SCIENCES R&D
    不详
    [J]. CHEMICAL & ENGINEERING NEWS, 2014, 92 (49) : 18 - 18